Skip to content

Comparison of Balanced Crystalloids and Normal Saline in Septic Patients

Comparison of Balanced Crystalloids and Normal Saline in Septic Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03685214
Enrollment
500
Registered
2018-09-26
Start date
2019-03-01
Completion date
2021-05-31
Last updated
2019-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Acute Kidney Injury, Septic Shock, Sepsis, Severe

Keywords

sepsis, intensive care unit, acetated Ringer's solution, AKI, normal saline, prognosis, continuous renal replacement therapy

Brief summary

In this prospective randomized controlled trial, investigators attempt to study the effects of acetated Ringer's solution on the prognosis and renal function of patients with sepsis in intensive care unit compared with normal saline, and provide evidence for current fluid resuscitation strategies for sepsis.

Detailed description

During the study period,either normal saline or acetated Ringer's solution will be assigned as resuscitation fluid to the septic patients meeting the inclusion criteria.It is anticipated that about 500 patients will be enrolled during the study period.

Interventions

DRUG0.9% saline

we use 0.9% saline in ICU patients with sepsis for resuscitation fluid.

we use balanced balanced crystalloids in ICU patients with sepsis for resuscitation fluid.

Sponsors

Wu Jieping Medical Foundation
CollaboratorOTHER
ZhiYong Peng
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

One model using normal saline for resuscitation fluid,the other using acetated Ringer's solution

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed sepsis aged 18\ 75 and accepted therapy in ICU

Exclusion criteria

* Need of Renal replacement treatment * End-stage renal failure * pregnant woman

Design outcomes

Primary

MeasureTime frameDescription
Development of kidney injury as defined by the KDIGO criteria.5 days after the admissionInvestigators will use the level of creatinine(μmol/L) and body weight adjusted urine(ml/h/kg) for severity assessment of kidney injury
Need of renal replacement treatmentAfter the admission and before the discharge from ICU,average 15 daysInvestigators will assess patients' kidney function everyday

Secondary

MeasureTime frameDescription
ICU stayAfter the admission and before the discharge from ICU,average 15 daysthe time of patients' requirement for critical care
28 days mortality28 days after the admission in ICUthe short time mortality

Countries

China

Contacts

Primary ContactLi He, investigator
helisoul@163.com008617798258617
Backup ContactLi He
helisoul@163.com008617798258617

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026